Benzinga | Mar 4, 2021 03:08PM EST

Caladrius Biosciences Receives FDA Orphan Designation Status For 'GCSF-mobilized autologous CD34+ cells' For Treatment Of Buerger's Disease

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=805020https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=805020